Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Doc file
Supplementary Figure 1
- eps file
Supplementary Table 1
- doc file
Supplementary Table 2
- doc file
Supplementary Table 3
- doc file